menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    2024 Excellence In Innovation Award Recognizes Pharmacy Trailblazer

    PR NEWSWIRE

    Upsher-Smith to Feature Presentations at AES 2024 Annual Meeting

    PR NEWSWIRE

    Upsher-Smith Presents Rare Disease Portfolio at CNS Annual Meeting

    PR NEWSWIRE

    Upsher Smith`s Generics Deflazacort Receives Approval in US

    FDA

    Upsher-Smith Selects PANTHERx Rare For Distribution Of TORPENZ

    PR NEWSWIRE

    Upsher-Smith Launches TORPENZ™ Tablets For Rare Diseases

    PR NEWSWIRE

    Upsher-Smith Enhances Promise Of Support Program For Rare Diseases

    PR NEWSWIRE

    Upsher-Smith Wins HDA DIANA Award

    PR NEWSWIRE

    Upsher Smith Labs Generic Brimonidine Tartrate Receives Approval in US

    FDA

    Upsher-Smith Named as 2024 Asap Alliance Excellence Award Finalist

    PR NEWSWIRE

    Upsher-Smith Rare Disease Portfolio At AAN 2024

    PR NEWSWIRE

    Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith

    PRESS RELEASE

    Upsher-Smith Launches Methimazole Tablets, USP

    PR NEWSWIRE

    Upsher-Smith and Naspa Announce Excellence In Innovation Award Recipients

    PR NEWSWIRE

    Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

    PRESS RELEASE

    Upsher-Smith Launches Pitavastatin Tablets

    PR NEWSWIRE

    Upsher-Smith Expands Portfolio With Launch of Mesalamine Extended-Release Capsules

    PR NEWSWIRE

    Upsher-Smith Launches Isotretinoin Capsules, Usp

    PR NEWSWIRE

    Upsher-Smith Divests Two Migraine Products

    PR NEWSWIRE

    Tonix Enters into Agreement to Acquire Products from Upsher-Smith Lab

    GLOBENEWSWIRE

    Upsher-Smith Adds Dicyclomine Hydrochloride Capsules, Usp To Its Product Line

    PR NEWSWIRE

    Upsher-Smith`s Generic Hydralazine HCL Receives Receives Approval in the U.S.

    FDA

    Upsher-Smith Launches Fluphenazine Hydrochloride Tablets

    PR NEWSWIRE

    UPSHER-SMITH LAUNCHES DICYCLOMINE HYDROCHLORIDE TABLETS

    PR NEWSWIRE

    Upsher-Smith Opens State-of-the-Art Manufacturing Facility

    CONTRACT PHARMA

    Upsher`s Generic Brimonidine Tartrate and Timolol Maleate Receives Approval in the U.S.

    FDA

    TAKU NAKAOKA NAMED CEO OF UPSHER-SMITH LABORATORIES

    PRNEWSWIRE

    Upsher Smith Labs` Generic Cholestyramine Receives Approval in the U.S.

    FDA

    Upsher Smith`s Generic Silodosin Receives Approval in the U.S.

    FDA

    Upsher Smith Lab`s Generic Isotretinoin Receives Approval In US

    FDA

    Upsher-Smith Launches Carbamazepine Extended-Release Tablets, USP

    PR NEWSWIRE

    Upsher-Smith Launches Isotretinoin Capsules

    PR NEWSWIRE

    Upsher-Smith and Rafarm Announce Launch of Moxifloxacin Ophthalmic Solution

    PRESS RELEASE

    Upsher-Smith Lab Generic Isotretinoin Receives Approval In US

    FDA

    Upsher Smith`s Generic Moxifloxacin Hydrochloride Approved in US

    FDA

    Upsher-Smith Launches Ramelteon Tablets

    UPSHER-SMITH

    Upsher-Smith Supports The American Headache Society`s Virtual 2020

    PRNEWSWIRE

    Upsher Smith Labs`s Generic Doxepin Hydrochloride Receives Approval In US

    FDA

    Upsher Smith`s Generic Ursodiol Approved in US

    FDA

    Upsher-Smith and AmbioPharm Announce Partnership Agreement to Develop

    PRESS RELEASE

    Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules

    PRNEWSWIRE

    Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules

    PRESS RELEASE

    Upsher Smith`s Generic Propafenone Hydrochloride Approved in US

    FDA

    Upsher-Smith Offers Help To People With Migraines During National Migraine

    PRNEWSWIRE

    Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration

    MARKETWATCH

    Upsher-Smith Lab`s Generic Amitriptyline Hydrochloride Receives Approval in US

    FDA

    Upsher-Smith Launches Fluvoxamine Maleate Tablets

    PR NEWSWIRE

    Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications

    FEDERALREGISTER

    Upsher-Smith Laboratories Launches Tosymra™ (sumatriptan) Nasal Spray

    PR NEWSWIRE

    Enforcement Report - Week of August 28, 2019

    FDA

    Upsher-Smith Launches Morphine Sulfate Tablets

    PR NEWSWIRE

    Acquisition of two treatments ‘rounds out’ Upsher-Smiths migraine portfolio

    IN-PHARMATECHNOLOGIST

    Upsher-Smith Lab`s Generic Morphine Sulfate Receives Approval in US

    FDA

    Dr Reddy`s to sell rights of 2 neurology drugs to Upsher-Smith for $110 mn

    BUSINESS STANDARD

    Upsher-Smith & NASPA Honor U.S. Pharmacists For Their Excellence In Innovation

    PR NEWSWIRE

    Glenmark Pharma gets USFDA nod for seizure treatment drug

    BUSINESSWIRE

    Jardiance (empagliflozin) : Boehringer Ingelheim vs. Zydus Pharms

    PATENT LITIGATION

    Enforcement Report - Week of October 31, 2018

    FDA

    Upsher-Smith Labs` Generic Clobazam Receives Approval in US

    FDA

    Upsher-Smith Labs` Generic Clobazam Receives Approval in US

    FDA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.